Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "Neuroscience"

123 News Found

Relmada Therapeutics bolsters Sepranolone Program with Michael Quirk as Senior Advisor
People | June 13, 2026

Relmada Therapeutics bolsters Sepranolone Program with Michael Quirk as Senior Advisor

Dr. Quirk said the program’s mechanism offers a targeted approach to disrupted brain signaling in compulsivity-related disorders


IIT Madras releases world’s most detailed 3D Atlas of human brainstem
News | June 12, 2026

IIT Madras releases world’s most detailed 3D Atlas of human brainstem

Developed by the Sudha Gopalakrishnan Brain Centre, the publicly accessible ANCHOR atlas maps over 200 brainstem structures at cellular resolution, offering new possibilities for neuroscience research and clinical applications


AbbVie scores key EU backing for Hepatitis C drug in push for earlier treatment
News | May 25, 2026

AbbVie scores key EU backing for Hepatitis C drug in push for earlier treatment

If cleared, MAVIRET would become one of the few therapies in the European Union approved to treat both acute and chronic hepatitis C infections


Bristol Myers Squibb & Anthropic redraw biopharma with Claude-powered enterprise AI
Digitisation | May 21, 2026

Bristol Myers Squibb & Anthropic redraw biopharma with Claude-powered enterprise AI

BMS is moving beyond conversational AI into what it describes as “agentic” systems


Dr Jitendra Singh commends SCTIMST doctors for treating  17,000 patients under AB-PMJAY
Hospitals | May 18, 2026

Dr Jitendra Singh commends SCTIMST doctors for treating 17,000 patients under AB-PMJAY

At the institute's 42nd convocation ceremony, Union Minister described its eight-institution MoU initiative as a unique collaborative effort that brings together premier national institutions to create a synergistic research ecosystem


Roche wins CE mark for Alzheimer’s blood test that could transform early diagnosis
R&D | May 13, 2026

Roche wins CE mark for Alzheimer’s blood test that could transform early diagnosis

The test is designed to help clinicians either rule in or rule out amyloid pathology in patients showing signs of cognitive decline


Novartis locks in $23 billion US expansion with seventh new facility
News | May 05, 2026

Novartis locks in $23 billion US expansion with seventh new facility

The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics


Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India
interviews | April 30, 2026

Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India

With the convergence of AI, robotics, and neuroscience, Motorica is advancing toward more intuitive, intent-driven prosthetic systems


Teva strikes $900M bet on breakthrough Tourette drug with Emalex buyout
News | April 30, 2026

Teva strikes $900M bet on breakthrough Tourette drug with Emalex buyout

The agreement could rise to $900 million if key commercial milestones are met


LVPEI launches Eye and Brain Centre in Hyderabad with support from D. E. Shaw India
Hospitals | April 27, 2026

LVPEI launches Eye and Brain Centre in Hyderabad with support from D. E. Shaw India

The centre will leverage AI-enabled tools to support research and diagnostics for complex eye–brain disorders